Despite slow client project initiations, the company's software remains crucial for clients' modeling efforts. Recent contract wins, like the $5 million one in Medical Communications, show the success of cross-selling strategies. Despite FDA disruptions, biosimulation adoption remains steady due to its efficiency.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay